New

Europe Ocular Drug Delivery Market

2021

Europe Ocular Drug Delivery Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Technology (Implantable Ocular Drug Delivery Systems, Particulate Drug Delivery Systems, Nano-Particle Drug Delivery System, and Others), Formulation Type (Liposomes and Nanoparticles, Solution, Emulsion, Suspension, and Ointment), Disease Type (Glaucoma, Diabetic Retinopathy, Dry Eye Syndrome, Macular Degeneration, Cataract, Diabetic Macular Edema, and Others), and End User (Hospitals, Ophthalmic Clinics, and Ambulatory Surgical Centers)

Publication Month: Nov 2021 | Report Code: TIPRE00025762 | No. of Pages: 152 | Category: Pharmaceuticals | Status: Published

Market Insights

Europe Ocular Drug Delivery Market to Grow at a CAGR of 6.9% to reach US$ 7,921.15 million from 2021 to 2028

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

The ocular drug delivery market in Europe is expected to grow to US$ 7,921.15 million by 2028 from US$ 4,967.64 million in 2021. The market is estimated to grow at a CAGR of 6.9% from 2021 to 2028.


The incidence of eye diseases has increased significantly. In recent years, various measures and efforts have been taken to create awareness and educate people regarding eye diseases, facilitating patients access to suitable medications and treatments for such conditions. Sightsavers—an international non-governmental organization—works in developing countries to treat and prevent eye diseases. A large population of India resides in rural areas, which has limited or no awareness about eye ailments. With its Rural Eye Health Programme, Sightsavers aims to create awareness, provide high-quality eye health services, and eradicate avoidable blindness in the rural population. Thus, the growing eye health awareness programs are likely to create growth opportunities for the market.

The European region has been massively hit by the COVID-19 spread, with most countries being in lockdown. Routine healthcare services were cancelled, and patients were recommended to avoid hospital visits to minimize the risk of COVID-19 transmission, leading to significant disruption to the provision of healthcare service and patient care. Ophthalmology represents one of the busiest and heavily outpatient-oriented specialties, with around 7.5 million outpatient appointments and over 500,000 surgical procedures being conducted every year in the United Kingdom. The lockdown has resulted in the cancellation of thousands of ophthalmic visits and surgeries; this has potentially led to permanent and significant harm to patient’s vision. Additionally, as per the recent survey – ‘Psychosocial impact of COVID-19 pandemic lockdown on people living with eye diseases in the UK’ which was conducted among the public with eye diseases, highlighted a significant negative psychosocial impact of lockdown on patients with visual impairment, with approximately 50% of the patients express fear of sight loss due to delayed review or treatment.

With the new features and technologies, companies can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the ocular drug delivery market. The Europe ocular drug delivery market is expected to grow at a good CAGR during the forecast period.
Europe ocular drug delivery market

Get more information on this report :


Europe Ocular Drug Delivery Market Segmentation

Europe Ocular Drug Delivery Market – By Technology

  • Implantable Ocular Drug Delivery Systems
  • Particulate Drug Delivery Systems
  • Nano-Particle Drug Delivery System
  • Others

Europe Ocular Drug Delivery Market – By Formulation Type

  • Solution
  • Ointment
  • Suspension
  • Emulsion
  • Liposomes and Nanoparticles

Europe Ocular Drug Delivery Market – By Disease type

  • Cataract
  • Dry Eye Syndrome
  • Macular Degeneration
  • Glaucoma
  • Diabetic Retinopathy
  • Diabetic Macular Edema
  • Others

Europe Ocular Drug Delivery Market – By End User

  • Hospitals
  • Ophthalmic Clinics
  • Ambulatory Surgical Centers

Europe Ocular Drug Delivery Market – By Country

  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Rest of Europe

Europe Ocular Drug Delivery Market – Companies Mentioned

  • AbbVie Inc.
  • Bausch Health Companies Inc.
  • Novartis AG
  • Clearside Biomedical, Inc
  • Alimera Sciences, Inc.
  • GRAYBUG VISION, INC

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Europe Ocular Drug Delivery Market – By Technology

1.3.2 Europe Ocular Drug Delivery Market – By Formulation Type

1.3.3 Europe Ocular Drug Delivery Market – By Disease Type

1.3.4 Europe Ocular Drug Delivery Market – By End User

1.3.5 Europe Ocular Drug Delivery Market – By Country

2. Europe Ocular Drug Delivery Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Europe Ocular Drug Delivery Market – Market Landscape

4.1 Overview

4.2 Expert Opinions

5. Europe Ocular Drug Delivery Market– Key Market Dynamics

5.1 Market Drivers

5.1.1 Surging Prevalence of Eye Disorders

5.2 Market Restraints

5.2.1 Drawbacks Associated with Ocular Drug Delivery

5.3 Market Opportunities

5.3.1 Raising Awareness About Vision Care

5.4 Future Trends

5.4.1 Emergence of Innovative Products

5.5 Impact analysis

6. Europe Ocular Drug Delivery – Market Analysis

6.1 Europe Ocular Drug Delivery Market Revenue Forecast and Analysis

7. Europe Ocular Drug Delivery Market Analysis – By Technology

7.1 Overview

7.2 Europe Ocular Drug Delivery Market Share by Technology 2021 & 2028 (%)

7.3 Implantable Ocular Drug Delivery Systems

7.3.1 Overview

7.3.2 Implantable Ocular Drug Delivery Systems Market Revenue and Forecast to 2028 (US$ Million)

7.4 Particulate Drug Delivery Systems

7.4.1 Overview

7.4.2 Particulate Drug Delivery Systems Market Revenue and Forecast to 2028 (US$ Million)

7.5 Nano-Particle Drug Delivery System

7.5.1 Overview

7.5.2 Nano-Particle Drug Delivery System Market Revenue and Forecast to 2028 (US$ Million)

7.6 Others

7.6.1 Overview

7.6.2 Others Market Revenue and Forecast to 2028 (US$ Million)

8. Europe Ocular Drug Delivery Market Analysis – By Formulation Type

8.1 Overview

8.1.1 Europe Ocular Drug Delivery Market, By Formulation Type 2021 & 2028 (%)

8.2 Liposomes and Nanoparticles Market

8.2.1 Overview

8.2.2 Liposomes and Nanoparticles Market Revenue and Forecasts to 2028 (US$ Million)

8.3 Solution

8.3.1 Overview

8.3.2 Solution Market Revenue and Forecasts to 2028 (US$ Million)

8.4 Emulsion

8.4.1 Overview

8.4.2 Emulsion Market Revenue and Forecasts to 2028 (US$ Million)

8.5 Suspension

8.5.1 Overview

8.5.2 Suspension Market Revenue and Forecasts to 2028 (US$ Million)

8.6 Ointment

8.6.1 Overview

8.6.2 Ointment Market Revenue and Forecasts to 2028 (US$ Million)

9. Europe Ocular Drug Delivery Market Analysis – By Disease Type

9.1 Overview

9.2 Europe Ocular Drug Delivery Market Share by Disease Type 2021 & 2028 (%)

9.3 Cataract

9.3.1 Overview

9.3.2 Cataract Market Revenue and Forecast to 2028 (US$ Million)

9.4 Dry Eye Syndrome

9.4.1 Overview

9.4.2 Dry Eye Syndrome Market Revenue and Forecast to 2028 (US$ Million)

9.5 Macular Degeneration

9.5.1 Overview

9.5.2 Macular Degeneration Market Revenue and Forecast to 2028 (US$ Million)

9.6 Glaucoma

9.6.1 Overview

9.6.2 Glaucoma Market Revenue and Forecast to 2028 (US$ Million)

9.7 Diabetic Retinopathy

9.7.1 Overview

9.7.2 Diabetic Retinopathy Market Revenue and Forecast to 2028 (US$ Million)

9.8 Diabetic Macular Edema

9.8.1 Overview

9.8.2 Diabetic Macular Edema Market Revenue and Forecast to 2028 (US$ Million)

9.9 Others

9.9.1 Overview

9.9.2 Others Market Revenue and Forecast to 2028 (US$ Million)

10. Europe Ocular Drug Delivery Market Analysis – By End User

10.1 Overview

10.2 Europe Ocular Drug Delivery Market Share, by End User, 2021 and 2028 (%)

10.3 Hospitals

10.3.1 Overview

10.3.2 Hospitals: Ocular Drug Delivery Market– Revenue and Forecast to 2028 (US$ Million)

10.4 Ophthalmic Clinics

10.4.1 Overview

10.4.2 Ophthalmic Clinics: Ocular Drug Delivery Market– Revenue and Forecast to 2028 (US$ Million)

10.5 Ambulatory Surgical Centers

10.5.1 Overview

10.5.2 Ambulatory Surgical Centers: Ocular Drug Delivery Market– Revenue and Forecast to 2028 (US$ Million)

11. Europe Ocular Drug Delivery Market – Country Analysis

11.1 Overview

11.1.1 Europe Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Country (%)

11.1.1.1 Germany Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.1.1 Germany Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.1.2 Germany Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Technology (US$ Million)

11.1.1.1.3 Germany Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Formulation Type (US$ Million)

11.1.1.1.4 Germany Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Disease Type (US$ Million)

11.1.1.1.5 Germany Ocular Drug Delivery Market Revenue and Forecasts to 2028, by End User (US$ Million)

11.1.1.2 UK Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.2.1 UK Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.2.2 UK Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Technology (US$ Million)

11.1.1.2.3 UK Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Formulation Type (US$ Million)

11.1.1.2.4 UK Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Disease Type (US$ Million)

11.1.1.2.5 UK Ocular Drug Delivery Market Revenue and Forecasts to 2028, by End User (US$ Million)

11.1.1.3 France Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.3.1 France Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.3.2 France Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Technology (US$ Million)

11.1.1.3.3 France Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Formulation Type (US$ Million)

11.1.1.3.4 France Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Disease Type (US$ Million)

11.1.1.3.5 France Ocular Drug Delivery Market Revenue and Forecasts to 2028, by End User (US$ Million)

11.1.1.4 Italy Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.4.1 Italy Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.4.2 Italy Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Technology (US$ Million)

11.1.1.4.3 Italy Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Formulation Type (US$ Million)

11.1.1.4.4 Italy Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Disease Type (US$ Million)

11.1.1.4.5 Italy Ocular Drug Delivery Market Revenue and Forecasts to 2028, by End User (US$ Million)

11.1.1.5 Spain Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.5.1 Spain Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.5.2 Spain Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Technology (US$ Million)

11.1.1.5.3 Spain Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Formulation Type (US$ Million)

11.1.1.5.4 Spain Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Disease Type (US$ Million)

11.1.1.5.5 Spain Ocular Drug Delivery Market Revenue and Forecasts to 2028, by End User (US$ Million)

11.1.1.6 Rest of Europe Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.6.1 Rest of Europe Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.6.2 Rest of Europe Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Technology (US$ Million)

11.1.1.6.3 Rest of Europe Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Formulation Type (US$ Million)

11.1.1.6.4 Rest of Europe Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Disease Type (US$ Million)

11.1.1.6.5 Rest of Europe Ocular Drug Delivery Market Revenue and Forecasts to 2028, by End User (US$ Million)

12. Impact Of COVID-19 Pandemic on Europe Ocular Drug Delivery Market

12.1 Impact Assessment of COVID-19 Pandemic

13. Industry Landscape

13.1 Overview

13.2 Organic Developments

13.2.1 Overview

13.3 Inorganic Developments

13.3.1 Overview

14. Company Profiles

14.1 AbbVie Inc.

14.1.1 Key Facts

14.1.2 Business Description

14.1.3 Products and Services

14.1.4 Financial Overview

14.1.5 SWOT Analysis

14.1.6 Key Developments

14.2 Bausch Health Companies Inc.

14.2.1 Key Facts

14.2.2 Business Description

14.2.3 Products and Services

14.2.4 Financial Overview

14.2.5 SWOT Analysis

14.2.6 Key Developments

14.3 GRAYBUG VISION, INC.

14.3.1 Key Facts

14.3.2 Business Description

14.3.3 Products and Services

14.3.4 Financial Overview

14.3.5 SWOT Analysis

14.3.6 Key Developments

14.4 Alimera Sciences, Inc.

14.4.1 Key Facts

14.4.2 Business Description

14.4.3 Products and Services

14.4.4 Financial Overview

14.4.5 SWOT Analysis

14.4.6 Key Developments

14.5 Novartis AG

14.5.1 Key Facts

14.5.2 Business Description

14.5.3 Products and Services

14.5.4 Financial Overview

14.5.5 SWOT Analysis

14.5.6 Key Developments

14.6 Clearside Biomedical, Inc.

14.6.1 Key Facts

14.6.2 Business Description

14.6.3 Products and Services

14.6.4 Financial Overview

14.6.5 SWOT Analysis

14.6.6 Key Developments

15. Appendix

15.1 About The Insight Partners

15.2 Glossary of Terms

LIST OF TABLES

Table 1. Germany Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Technology US$ Million)

Table 2. Germany and Middle East and Africa Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Formulation Type (US$ Million).

Table 3. Germany and Middle East and Africa Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Disease Type (US$ Million).

Table 4. Germany Ocular Drug Delivery Market Revenue and Forecasts to 2028, by End User US$ Million)

Table 5. UK Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Technology US$ Million)

Table 6. UK Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Formulation Type (US$ Million).

Table 7. UK Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Disease Type (US$ Million).

Table 8. UK Ocular Drug Delivery Market Revenue and Forecasts to 2028, by End User US$ Million)

Table 9. France Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 10. France Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Formulation Type (US$ Million)

Table 11. France Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Disease Type (US$ Million)

Table 12. France Ocular Drug Delivery Market Revenue and Forecasts to 2028, by End User (US$ Million)

Table 13. Italy Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 14. Italy Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Formulation Type (US$ Million)

Table 15. Italy Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Disease Type (US$ Million)

Table 16. Italy Ocular Drug Delivery Market Revenue and Forecasts to 2028, by End User (US$ Million)

Table 17. Spain Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 18. Spain Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Formulation Type (US$ Million)

Table 19. Spain Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Disease Type (US$ Million)

Table 20. Spain Ocular Drug Delivery Market, by End User – Revenue and Forecast to 2028 by End User (USD Million)

Table 21. Rest of Europe Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 22. Rest of Europe Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Formulation Type (US$ Million)

Table 23. Rest of Europe Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Disease Type (US$ Million)

Table 24. Rest of Europe Ocular Drug Delivery Market Revenue and Forecasts to 2028, by End User (US$ Million)

Table 25. Organic Developments Done By Companies

Table 26. Inorganic Developments Done by Companies

Table 27. Glossary of Terms, Ocular Drug Delivery Market

LIST OF FIGURES

Figure 1. Europe Ocular Drug Delivery Market Segmentation

Figure 2. Europe Ocular Drug Delivery Market Segmentation, By Country

Figure 3. Europe Ocular Drug Delivery Market Overview

Figure 4. Implantable Ocular Drug Delivery Systems Segment Held the Largest Share of the Technology Segment in Ocular Drug Delivery Market

Figure 5. The UK to Show Significant Growth During Forecast Period

Figure 6. Europe Ocular Drug Delivery Market, Industry Landscape

Figure 7. Europe PEST Analysis

Figure 8. Europe Ocular Drug Delivery Market Impact Analysis of Driver and Restraints

Figure 9. Europe Ocular Drug Delivery Market – Revenue Forecast and Analysis – 2020- 2028

Figure 10. Europe Ocular Drug Delivery Market Share by Technology 2021 & 2028 (%)

Figure 11. Implantable Ocular Drug Delivery Systems Market Revenue and Forecasts to 2028 (US$ Million)

Figure 12. Particulate Drug Delivery Systems Market Revenue and Forecasts to 2028 (US$ Million)

Figure 13. Nano-Particle Drug Delivery System Market Revenue and Forecasts to 2028 (US$ Million)

Figure 14. Others Market Revenue and Forecasts to 2028 (US$ Million)

Figure 15. Europe Ocular Drug Delivery Market, By Formulation Type 2021 & 2028 (%)

Figure 16. Liposomes and Nanoparticles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 17. Solution Market Revenue and Forecasts to 2028 (US$ Million)

Figure 18. Emulsion Market Revenue and Forecasts to 2028 (US$ Million)

Figure 19. Suspension Market Revenue and Forecasts to 2028 (US$ Million)

Figure 20. Ointment Market Revenue and Forecasts to 2028 (US$ Million)

Figure 21. Europe Ocular Drug Delivery Market Share by Disease Type 2021 & 2028 (%)

Figure 22. Cataract Market Revenue and Forecasts to 2028 (US$ Million)

Figure 23. Dry Eye Syndrome Market Revenue and Forecasts to 2028 (US$ Million)

Figure 24. Macular Degeneration Market Revenue and Forecasts to 2028 (US$ Million)

Figure 25. Glaucoma Market Revenue and Forecasts to 2028 (US$ Million)

Figure 26. Diabetic Retinopathy Market Revenue and Forecasts to 2028 (US$ Million)

Figure 27. Diabetic Macular Edema Market Revenue and Forecasts to 2028 (US$ Million)

Figure 28. Others Market Revenue and Forecasts to 2028 (US$ Million)

Figure 29. Europe Ocular Drug Delivery Market Share, by End User, 2021 and 2028 (%)

Figure 30. Hospitals: Ocular Drug Delivery Market– Revenue and Forecast to 2028 (US$ Million)

Figure 31. Ophthalmic Clinics: Ocular Drug Delivery Market– Revenue and Forecast to 2028 (US$ Thousand)

Figure 32. Ambulatory Surgical Centers: Ocular Drug Delivery Market– Revenue and Forecast to 2028 (US$ Thousand)

Figure 33. Europe: Ocular Drug Delivery Market Revenue Overview, by Country, 2021 (US$ MILLION)

Figure 34. Europe Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Country (%)

Figure 35. Germany Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Million)

Figure 36. UK Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Million)

Figure 37. France Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Million)

Figure 38. Italy Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Million)

Figure 39. Spain Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Million)

Figure 40. Rest of Europe Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Million)

Figure 41. Impact of COVID-19 Pandemic in European Country Markets

  1. AbbVie Inc.                                              
  2. Bausch Health Companies Inc.            
  3. Novartis AG                                            
  4. Clearside Biomedical, Inc                      
  5. Alimera Sciences, Inc.                           
  6. GRAYBUG VISION, INC                      
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe ocular drug delivery market
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in Europe ocular drug delivery market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the ocular drug delivery market as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution  
TIPRE00025762
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.